Skip to main content
SpringerLink
Log in
Book cover

Ventricular Assist Devices in Advanced-Stage Heart Failure pp 23–39Cite as

The State of Ventricular Assist Device Therapy Today

  • Chapter
  • First Online:

  • 1538 Accesses

Abstract

Despite advances in most cardiovascular care, heart failure remains a predominant problem in industrialized nations, with significant mortality, morbidity, and associated costs. The development of left ventricular assist devices, first as a bridge to transplant and then as destination therapy, has significantly improved survival and quality of life of patients with end-stage heart failure. Initial durable ventricular assist devices were large pulsatile devices, but later models have become much smaller, more effective, and more durable as continuous-flow pumps, both axial and centrifugal flow. While these devices have some risk of complications and current models require anticoagulation, patients’ overall quality of life and survival have been significantly affected in a positive way. As patient survival has improved, the growth of implantation and care of LVAD patients has created a paradigm of “hub and spoke ” model for transplant centers and non-transplant open heart centers to improve access and care to patient for left ventricular assist devices.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Braunwald E. Heart failure. JACC Heart Fail. 2013;1(1):1–20. doi:10.1016/j.jchf.2012.10.002.

    Article  Google Scholar 

  2. Shiba N, Shimokawa H. Chronic heart failure in Japan: implications of the CHART studies. Vasc Health Risk Manag. 2008;4(1):103–13.

    Article  PubMed  Google Scholar 

  3. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the international society for heart and lung transplantation. Circulation. 2009;119(14):e391–479. doi:10.1161/CIRCULATIONAHA.109.192065.

    Google Scholar 

  4. Cleland JGF, Clark AL. Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure. J Am Coll Cardiol. 2003;42(7):1234–7. doi:10.1016/s0735-1097 (03)00948-3.

    Google Scholar 

  5. Metra M, Ponikowski P, Dickstein K, McMurray JJ, Gavazzi A, Bergh CH, Fraser AG, Jaarsma T, Pitsis A, Mohacsi P, Bohm M, Anker S, Dargie H, Brutsaert D, Komajda M. Heart failure association of the european society of c. advanced chronic heart failure: a position statement from the study group on advanced heart failure of the heart failure association of the european society of cardiology. Eur J Heart Fail. 2007;9(6–7):684–94. doi:10.1016/j.ejheart.2007.04.003.

    Google Scholar 

  6. OPTN/SRTR. Organ procurement and transplantation network (OPTN) and scientific registry of transplant recipients (SRTR). 2011 Annual data report. Department of Health and Human Services Health Resources and Services Administration, Healthcare systems Bureau, Division of Transplantation; 2012. http://optn.transplant.hrsa.gov/latestData/rptData.asp. Accessed 21 April 2012.

  7. Boyle AJ. State of the state: opportunities and challenges today in VAD therapy. In: Presentation done at 2013 thoratec mechanical circulatory support (MCS) conference, Orlando, 2013.

    Google Scholar 

  8. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL, Meier P. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435–43. doi: 10.1056/NEJMoa012175.

    Google Scholar 

  9. Griffith BP, Kormos RL, Borovetz HS, Litwak K, Antaki JF, Poirier VL, et al. HeartMate II left ventricular assist system: from concept to first clinical use. Ann Thorac Surg. 2001;71(90030):S116–20.

    Google Scholar 

  10. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139(5):1316–24.

    Google Scholar 

  11. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357(9):885–96. doi: 10.1056/NEJMoa067758.

    Google Scholar 

  12. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54(4):312–21. doi:10.1016/j.jacc.2009.03.055.

    Google Scholar 

  13. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32(2):141–56. doi:10.1016/j.healun.2012.12.004.

    Google Scholar 

  14. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241–51. doi: 10.1056/NEJMoa0909938.

    Google Scholar 

  15. Jorde UP, Kushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, et al. 1 Initial results of the destination therapy post-FDA-approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry. J Heart Lung Transplant. 2012;31(4):S10.

    Google Scholar 

  16. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson L, Miller M, et al. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg. 2012;144(3):584–603. doi:10.1016/j.jtcvs.2012.05.044.

    Google Scholar 

  17. Garbade J, Bittner HB, Barten MJ, Mohr FW. Current trends in implantable left ventricular assist devices. Cardiol Res Pract. 2011;2011:290561. doi: 10.4061/2011/290561.

  18. Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, et al. The 2013 international society for heart and lung transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32(2):157–87. doi:10.1016/j.healun.2012.09.013.

    Google Scholar 

  19. Godshall D. HeartWare® Ventricular Assist Device (HVAD®) circulatory systems device panel. 2012. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM302187.pdf. Accessed 21 April 2013.

  20. Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, Steidley DE, et al. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail. 2012;5(2):241–8. doi:10.1161/CIRCHEARTFAILURE.111.963991.

    Google Scholar 

  21. Crow S, John R, Boyle A, Shumway S, Liao K, Colvin-Adams M, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg. 2009;137(1):208–15. doi:10.1016/j.jtcvs.2008.07.032.

    Google Scholar 

  22. Boyle AJ, Ascheim DD, Russo MJ, Kormos RL, John R, Naka Y, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant. 2011;30(4):402–7.

    Google Scholar 

  23. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant. 2012;31(2):117–26. doi:10.1016/j.healun.2011.12.001.

  24. Katz MR, Horn EM, Dickinson MG, Zeevi GR, Salemi A, Slater JP. 4 Outcomes of patients implanted with a left ventricular assist device at non-transplant open heart surgery centers. J Heart Lung Transplant. 2012;31(4):S11.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Heart Failure Center, The Georgia Heart Center, The Medical Center of Central Georgia, Mercer University School of Medicine, 777 Hemlock Street, MSC #53, Macon, GA, 31201, USA

    Erskine A. James & John B. O’Connell

Authors
  1. Erskine A. James
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John B. O’Connell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erskine A. James .

Editor information

Editors and Affiliations

  1. Dept. of The Therapeutic Strategy for Heart Failure, The University of Tokyo Hospital, Graduate School of Medicine, The University of Tokyo, Tokyo, Tokyo, Japan

    Shunei Kyo

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Japan

About this chapter

Cite this chapter

James, E.A., O’Connell, J.B. (2014). The State of Ventricular Assist Device Therapy Today. In: Kyo, S. (eds) Ventricular Assist Devices in Advanced-Stage Heart Failure. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54466-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54466-1_2

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54465-4

  • Online ISBN: 978-4-431-54466-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation